The standout genes were BRCA1, BRCA2, and PALB2. Variants leading to truncating/incomplete proteins in these genes correlated with an increased breast cancer risk, which were statistically significant (all P-values less than 0.0001), underscoring their crucial role in the genetic landscape of breast cancer. This evidence concerns the gene PALB2 and breast carcinoma.